ciprofloxacin has been researched along with Central Nervous System Diseases in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report four cases of serious form of Mediterranean spotted fever with neurological feature." | 1.32 | [Neurological feature of Mediterranean spotted fever: a study of four cases]. ( Alioua, Z; Boudi, O; Bourazza, A; Erragragui, Y; Ghfir, M; Karouach, K; Lamsyah, H; Mossedaq, R; Sedrati, O, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alioua, Z | 1 |
| Bourazza, A | 1 |
| Lamsyah, H | 1 |
| Erragragui, Y | 1 |
| Boudi, O | 1 |
| Karouach, K | 1 |
| Ghfir, M | 1 |
| Mossedaq, R | 1 |
| Sedrati, O | 1 |
| Iakovlev, VP | 1 |
| Svetukhin, AM | 1 |
| Blatun, LA | 1 |
| Ukhin, SA | 1 |
| Stahlmann, R | 1 |
1 review available for ciprofloxacin and Central Nervous System Diseases
| Article | Year |
|---|---|
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastro | 2004 |
2 other studies available for ciprofloxacin and Central Nervous System Diseases
| Article | Year |
|---|---|
[Neurological feature of Mediterranean spotted fever: a study of four cases].
Topics: Anti-Infective Agents; Boutonneuse Fever; Central Nervous System Diseases; Ciprofloxacin; Humans; Ma | 2003 |
Clinical toxicological aspects of fluoroquinolones.
Topics: Anti-Infective Agents; Bacterial Infections; Cardiovascular Diseases; Central Nervous System Disease | 2002 |